!DOCTYPE HTML>
Organization and Delivery of Services
Standardization of Oral Liquid Medication Concentrations (1401)
Source: Council on Pharmacy Practice
To advocate for the development of nationally standardized drug concentrations for oral liquid medications; further,
To encourage all health care providers and organizations to standardize concentrations of oral liquid medications; further,
To promote effective instruction of patients and caregivers on how to properly measure and administer oral liquid medications.
Documentation of Patient-Care Services in the Permanent Health Record (1419)
Source: Council on Pharmacy Management
To advocate for public and organizational policies that support pharmacist documentation of patient-care services in the permanent patient health record to ensure accurate and complete documentation of the care provided to patients and to validate the impact of pharmacist patient care on patient outcomes and total cost of care; further,
To advocate that electronic health records be designed with a common documentation space to accommodate all health care team members and support the communication needs of pharmacy.
This policy supersedes ASHP policy 0407.
Standardization of Intravenous Drug Concentrations (1306)
Source: Council on Pharmacy Practice
To develop nationally standardized drug concentrations and dosing units for commonly used high-risk drugs that are given as continuous infusions to adult and pediatric patients; further,
To encourage all hospitals and health systems to use infusion devices that interface with their information systems and include standardized drug libraries with dosing limits, clinical advisories, and other patient-safety-enhancing capabilities; further,
To encourage interprofessional collaboration on the adoption and implementation of standardized drug concentrations and dosing units in hospitals and health systems.
This policy supersedes ASHP policy 0807.
Source: Council on Therapeutics
To define medication overuse as use of a medication when the potential risks of using the drug outweigh the potential benefits for the patient; further,
To recognize that medication overuse is inappropriate and can result in patient harm and increased overall health care costs; further,
To advocate that pharmacists take a leadership role in interprofessional efforts to minimize medication overuse.
Drug-Containing Devices (1313)
Source: Council on Therapeutics
To recognize that use of drug-containing devices (also known as combination devices) has important clinical and safety implications for patient care; further,
To advocate that use of such devices be documented in the patient’s medical record to support clinical decision-making; further,
To encourage pharmacists to participate in interprofessional efforts to evaluate and create guidance on the use of these products through the pharmacy and therapeutics committee process to ensure patient safety and promote cost-effectiveness; further,
To advocate that the Food and Drug Administration (FDA) and device manufacturers increase the transparency of the FDA approval process for drug-containing devices, including access to data used to support approval; further,
To encourage research that evaluates the clinical and safety implications of drug-containing devices to inform product development and guide clinical practice.
Qualifications and Competencies Required to Prescribe Medications (1202)
Source: Council on Education and Workforce Development
To affirm that prescribing is a collaborative process that includes patient assessment, understanding of the patient’s diagnoses, evaluation and selection of available treatment options, monitoring to achieve therapeutic outcomes, patient education, and adherence to safe and cost-effective prescribing practices; further,
To affirm that safe prescribing of medications, performed independently or collaboratively, requires competent professionals who complement each others’ strengths at each step; further,
To explore the creation of prescribing standards that would apply to all who initiate or modify medication orders or prescriptions and that would facilitate development of competencies and training of prescribers; further,
To encourage research on the effectiveness of current educational processes designed to train prescribers.
Source: Council on Pharmacy Management
To recognize that continuity of patient care is a vital requirement in the appropriate use of medications; further,
To strongly encourage pharmacists to assume professional responsibility for ensuring the continuity of care as patients move from one setting to another (e.g., ambulatory care to inpatient care to home care); further,
To encourage the development, optimization, and implementation of information systems that facilitate sharing of patient-care data across care settings and providers; further,
To advocate that payers and health systems provide sufficient resources to support effective transitions of care; further,
To encourage the development of strategies to address the gaps in continuity of pharmacist patient care services.
This policy supersedes ASHP policy 0301.
Pharmacist Prescribing in Interprofessional Patient Care (1213)
Source: Council on Pharmacy Practice
To define pharmacist prescribing as follows: patient assessment and the selection, initiation, monitoring, adjustment, and discontinuation of medication therapy pursuant to diagnosis of a medical disease or condition; further,
To advocate that health care delivery organizations establish credentialing and privileging processes that delineate the scope of pharmacist prescribing within the hospital or health system and to ensure that pharmacists who prescribe are competent and qualified to do so.
Pharmacist’s Role in Team-Based Care (1215)
Source: Council on Pharmacy Practice
To recognize that pharmacist participation in interprofessional health care teams as the medication-use expert increases the capacity and efficiency of teams for delivering high-quality care; further,
To advocate to policymakers, payers, and other stakeholders for the inclusion of pharmacists as care providers within team-based care; further,
To assert that pharmacists are responsible for coordinating the care they provide with that provided by other members of the health care team and are accountable to the patient and to the health care team for the outcomes of that care; further,
To urge pharmacists on health care teams to collaborate with other team members in establishing quality measures for care provided by those teams.
Collaborative Drug Therapy Management (1217)
Source: Council on Public Policy
To pursue the development of federal and state legislative and regulatory provisions that authorize collaborative drug therapy management by pharmacists; further,
To advocate expansion of federal and state legislative and regulatory provisions that optimize pharmacists’ ability to provide the full range of professional services within their scope of expertise; further,
To acknowledge that as part of these advanced collaborative practices, pharmacists, as active members in team-based care, must be responsible and accountable for medication-related outcomes; further,
To support affiliated state societies in the pursuit of state-level collaborative drug therapy management authority for pharmacists.
This policy supersedes ASHP policy 9812.
Source: Council on Therapeutics
To recognize that improving medication adherence should be a key component of strategies to improve the quality and safety of patient care only when adherence improvement efforts include the following as required elements: (1) assessing the appropriateness of therapy, (2) providing patient education, and (3) ensuring patient comprehension of information necessary to support safe and appropriate use of prescribed therapies; further,
To advocate that pharmacists, because of their distinct knowledge, skills, and abilities, should take a leadership role in multidisciplinary efforts to develop, implement, monitor, and maintain effective strategies for improving medication adherence; further,
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
